Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YH001 in Advanced Solid Tumors and Melanoma (Phase I/II, China)
CTR20202475Phase 2Completed
- Sponsor
- Youhe Biopharma
- Start
- Dec 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YH001 in Nonhematologic neoplasms, melanoma, sponsored by Youhe Biopharma. Started Dec 2020; status: completed.
02
Drugs
YH001
03
Conditions
Nonhematologic neoplasmsmelanoma
Beyond the preview
Go deeper on CTR20202475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202475.